Weight loss following lisdexamfetamine in children and adolescents with attention deficit hyperactivity disorder and overweight and obesity
Reduction in BMI for age was noted for up to 2 years following initiation of lisdexamfetamine in children with ADHD and overweight and obesity. Further studies are warranted to study the weight loss effect of lisdexamfetamine in children with obesity.
Authors
- Roland Hentz
- Kaitlin N. Leopold (ORCID: https://orcid.org/0000-0003-0317-4172)
- Mostafa Salama (ORCID: https://orcid.org/0009-0001-7451-1503)
- Seema Kumar (ORCID: https://orcid.org/0000-0001-8004-4924)
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Pediatric Obesity
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1111/ijpo.70024
- Citations
- 4
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 5.88